Key result
Diuretic therapy remains the central pillar for managing congestion in patients with chronic heart failure, despite the lack of clinical trials demonstrating a survival benefit.
Loop diuretics remain a central pillar of therapy for managing congestion in chronic heart failure, though diuretic resistance remains a clinical challenge.
Answers are grounded in this paper and cite their sources.
Diuretics remain central for congestion relief in chronic HF despite absent survival data; leaves open need for RCTs on mortality benefit.
Heart failure is a major public health problem in developed countries. Many of the clinical manifestations of heart failure are due to congestion and fluid retention, therefore diuretic therapy occupied for a long time an important place in the management of these patients. All diuretics increase the excretion of water from the body, each of the classes of diuretics achieving this effect in a distinct manner. Given the magnitude of their effect, loop diuretics are the central pillar of diuretic therapy in many patients with heart failure. Resistance to diuretic therapy is one of the management issues for medical science, which is looking for solutions.
No takes yet. Share an insight, caveat, or question.
Diaconu et al. (2016) conducted a review in Chronic heart failure. Diuretics was evaluated. Diuretic therapy remains the central pillar for managing congestion in patients with chronic heart failure, despite the lack of clinical trials demonstrating a survival benefit.
Synapse has enriched 10 related papers. Consider them for comparative context: